News for 908 Devices Inc. (MASS)

908 Devices boosts financial stability with a $70M desktop sale. Read why I'm taking my bearish view off the table for now on MASS stock.

Revenue (Q4 2024): $18.8 million, up 31% from $14.4 million in Q4 2023.Handheld Revenue (Q4 2024): $13.6 million, up 22% from $11.1 million in Q4 2023.Desktop

Mar 04, 2025 / 01:30PM GMTOperator Hello and welcome to the 908 Devices Fourth Quarter 2024 Financial Results. My name is Becky and I'll be your operator today.

908 Devices (MASS) delivered earnings and revenue surprises of 8.57% and 10.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

908 Devices (MASS) stock soars 71% premarket as Repligen (RGEN) announces $70M acquisition of its bioprocessing analytics portfolio. Read more here.

Revenue: $18.8 million for Q4 2024, surpassing the estimated $16.39 million and marking a 31% increase year-over-year.Full Year Revenue: $59.6 million for 2024

Discover how 908 Devices' Q4 revenue surged by 31% YoY, beating estimates by $1.75M, despite a GAAP EPS miss.

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarte

**media[556718]**

[url="]908 Devices Inc.[/url] (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will participat

Transaction Overview On December 31, 2024, Catherine Wood (Trades, Portfolio), a prominent figure in the investment world, executed a significant transaction in

Florida- based Safe & Green Holdings Corp. (SGBX) is up over 155 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced preliminary unaudited financial

908 Devices (MASS) expects Q4 revenue of $17.2M, 20% growth from Q4 2023.

908 Devices reports 15% annual revenue growth

Transaction Overview On September 30, 2024, Catherine Wood (Trades, Portfolio), the founder of ARK, executed a significant reduction in holdings of 908 Devices

908 Devices stock hits 52-week low at $1.82 amidst market challenges

Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters

908 Devices stock hits 52-week low at $2.19 amid market challenges